Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Gilliland

Showing results (81-90 of 182) with videos related to

Pageof 19
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse modelLouise M Kelly, Jeffrey L Kutok, Ifor R Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2006
Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancyKatharina Wagner, Pu Zhang, Frank Rosenbauer, et al.
Protein Engineering, Design & Selection : PEDS|October 15, 2016
Engineering a targeted delivery platform using CentyrinsShalom D Goldberg, Rosa M F Cardoso, Tricia Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosisAnimesh Pardanani, Jason R Gotlib, Catriona Jamieson, et al.
Blood|June 19, 2008
Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cellsWinnie F Tam, Ting-Lei Gu, Jing Chen, et al.
Experimental Hematology|December 24, 2014
Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant miceSamuel J Taylor, Christine B F Thien, Samantha A Dagger, et al.
Cell Stem Cell|July 14, 2015
Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor CellsXiongwei Cai, Long Gao, Li Teng, et al.
Experimental Hematology|August 30, 2008
Genetic profiling of myeloproliferative disorders by single-nucleotide polymorphism oligonucleotide microarrayNorihiko Kawamata, Seishi Ogawa, Go Yamamoto, et al.
Cancer|December 22, 2005
The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia veraAyalew Tefferi, Terra L Lasho, Susan M Schwager, et al.
Blood|December 14, 2011
KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in miceLing Zhao, Jan J Melenhorst, Lemlem Alemu, et al.
Pageof 19

Showing results (81-90 of 182) with videos related to

Sort By:
Pageof 19
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse modelLouise M Kelly, Jeffrey L Kutok, Ifor R Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2006
Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancyKatharina Wagner, Pu Zhang, Frank Rosenbauer, et al.
Protein Engineering, Design & Selection : PEDS|October 15, 2016
Engineering a targeted delivery platform using CentyrinsShalom D Goldberg, Rosa M F Cardoso, Tricia Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosisAnimesh Pardanani, Jason R Gotlib, Catriona Jamieson, et al.
Blood|June 19, 2008
Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cellsWinnie F Tam, Ting-Lei Gu, Jing Chen, et al.
Experimental Hematology|December 24, 2014
Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant miceSamuel J Taylor, Christine B F Thien, Samantha A Dagger, et al.
Cell Stem Cell|July 14, 2015
Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor CellsXiongwei Cai, Long Gao, Li Teng, et al.
Experimental Hematology|August 30, 2008
Genetic profiling of myeloproliferative disorders by single-nucleotide polymorphism oligonucleotide microarrayNorihiko Kawamata, Seishi Ogawa, Go Yamamoto, et al.
Cancer|December 22, 2005
The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia veraAyalew Tefferi, Terra L Lasho, Susan M Schwager, et al.
Blood|December 14, 2011
KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in miceLing Zhao, Jan J Melenhorst, Lemlem Alemu, et al.
Pageof 19